A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System Events for Trametinib

This research investigates adverse drug events (ADEs) linked to trametinib, utilizing data from the FDA Adverse Event Reporting System (FAERS) database, covering the period from Q2 2013 to Q4 2023.